A Gate to the Future of Gastric Cancer Treatment

This was the theme of the 9th International Gastric Cancer Congress held in Coex, Seoul, Korea from April 20-23, 2011. Four days full of special lectures, panel discussions, workshops and case conferences…bringing together experts in their fields from all around the world.

The 2011 congress included 2,000 participants representing 70 countries. We are very proud that five members of No Stomach For Cancer’s Scientific Advisory Board not only attended the congress, but were presenters in their areas of expertise.

SAB Board Members in Seoul

Fatima Carneiro, David Huntsman, Greg Lauwers, Parry Guilford, not pictured is Sam Yoon (behind the camera)

We applaud the continuing commitment and research achievements of these distinguished scientists and physicians.

Sam S. Yoon, MD

Sam Yoon

Presentations by NSFC Scientific Advisory Board Members

Session Title: “Standardization of pathology; premalignant & malignant”
Subject: Gastric Dysplasia: the American View, Gregory Lauwers, USA
Subject: European View of Gastric Epithelial Lesions, Fatima Carneiro, Portugal

Session Title: “7th TNM classification; What is the next?”
Subject: 7th TNM classification; A western viewpoint, Sam S. Yoon, with colleague from Singapore

Session Title: “GEJ cancer; esophageal or gastric cancer?”
Subject: Carcinogenesis and histology of EGJ carcinoma, Gregory Lauwers, USA

Session Title: “FGC (Familial Gastric Cancer)”
Subject: Hereditary diffuse gastric cancer: 10 years of successes, new challenges and new opportunities, David Huntsman, Canada
Subject: Prophylactic gastrectomy, a surgeon’s perspective, Sam S. Yoon, USA
Subject: Guidelines for the management of hereditary diffuse gastric cancer, Parry Guilford, New Zealand

4 Responses to A Gate to the Future of Gastric Cancer Treatment

  1. Cindy Chelcun says:

    Hi Teri and Teresa,

    Dr. Greg Lauwers, Mass. General Hospital, replied to our inquiry with the following: “Cancer of the gastroesophageal junction is an area of significant interest in the literature. In a nutshell, since there is no gastroesophageal “organ,” the tumors of that region are either esophageal or gastric in origin. Obviously, given that this is a border zone, it may be very difficult to estimate anatomically whether a lesion arises from one organ to the other. This is important since distinct pathogenetic processes are associated with the development of cancer in the esophagus (by reflux, etc.) and in the stomach (possibly gastroesophageal reflux in the proximal stomach or Helicobacter pylori). There is some indication that most lesions arising in Western patients are indeed tumors of the esophagus arising at the very lowest section of the organ.” There is a paper from a study in the U.K. which we will ask Dr. Lauwers to provide a link to, for further reading.

  2. Cindy says:

    Teresa and Teri,
    If you can remind me next week with an email to Cindy@Nostomachforcancer.org (I’m not at home this week), I will contact the Scientific Advisory Board members to pass along your inquiries.

  3. Teresa Feeney says:

    Also are there transcripts or video of the presentations? While I’m sure they are very technical, I would love to be able to read or see them!

  4. Teri Garin says:

    Does anyone have info on what the lecture related to GEJ cancer said …were there any conclusions that it is directly linked to gastric cancer somehow?

Leave a Reply

Return to Top
Contribute Now

Be Our Guest

Share your experience. Learn how you can become a guest contributor to the NSFC Blog.